n-vinyl-2-pyrrolidinone has been researched along with Carcinoma, Intraepithelial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, WW; Kho, KW; Lau, WK; Lee, LS; Lim, PL; Olivo, M; Ramaswamy, B; Thong, PS | 1 |
| Waidelich, R | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Chlorophyllides; Feasibility Studies; Female; Humans; Injections, Intravenous; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Porphyrins; Povidone; Protoporphyrins; Radiation-Sensitizing Agents; Treatment Failure; Urinary Bladder Neoplasms | 2010 |
Comment on "Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle-invasive bladder cancer" by Lui Shiong Lee et al. [Photodiagn Photodyn Ther 2010;7:213-20].
Topics: Carcinoma in Situ; Carcinoma, Transitional Cell; Chlorophyllides; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Porphyrins; Povidone; Protoporphyrins; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 2010 |